Shares of TerrAscend Corp. (OTCMKTS:TRSSF – Get Rating) have been assigned an average rating of “Buy” from the eight brokerages that are presently covering the firm, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $12.73.
TRSSF has been the subject of a number of recent analyst reports. Cantor Fitzgerald raised their target price on TerrAscend from $7.65 to $7.90 and gave the company an “overweight” rating in a report on Thursday, March 17th. Atb Cap Markets reissued an “outperform” rating on shares of TerrAscend in a report on Wednesday, March 16th. Clarus Securities reissued a “buy” rating on shares of TerrAscend in a report on Thursday, March 17th. Finally, Needham & Company LLC assumed coverage on TerrAscend in a research note on Thursday, March 17th. They set a “buy” rating and a $8.00 price target for the company.
TerrAscend stock traded up $0.04 during midday trading on Monday, reaching $5.60. The company’s stock had a trading volume of 77,402 shares, compared to its average volume of 364,329. TerrAscend has a fifty-two week low of $4.59 and a fifty-two week high of $12.00. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.04 and a quick ratio of 1.43. The stock’s 50 day simple moving average is $5.50 and its 200 day simple moving average is $5.79.
TerrAscend Company Profile (Get Rating)
TerrAscend Corp. produces and sells medical cannabis products. The firm owns several businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections and Arise Bioscience Inc The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.
- Get a free copy of the StockNews.com research report on TerrAscend (TRSSF)
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
- Top 3 Safe Stocks for Conservative Investors
- Array Technologies Stock Giving Another Ground Floor Entry
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.